Zheng Y - Search Results

1

Synthesis and quantum chemical studies of new 4-aminoquinazoline derivatives as Aurora A/B kinase inhibitors.

Zheng M, Zheng Y, Xue Y, Liu Y, An L, Zhang L, Ji M, Xue B, Wu X, Gong X, Gu N, Zhan X. Zheng M, et al. Among authors: zheng y. Chem Biol Drug Des. 2013 Mar;81(3):399-407. doi: 10.1111/cbdd.12089. Epub 2012 Dec 26. Chem Biol Drug Des. 2013. PMID: 23279802

2

Design, synthesis, and in vitro antitumor activity evaluation of novel 4-pyrrylamino quinazoline derivatives.

Wu X, Li M, Tang W, Zheng Y, Lian J, Xu L, Ji M. Wu X, et al. Among authors: zheng y. Chem Biol Drug Des. 2011 Dec;78(6):932-40. doi: 10.1111/j.1747-0285.2011.01234.x. Epub 2011 Oct 24. Chem Biol Drug Des. 2011. PMID: 21895983 Free PMC article.

3

Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.

Zheng Y, Zheng M, Ling X, Liu Y, Xue Y, An L, Gu N, Ji M. Zheng Y, et al. Among authors: zheng m. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3523-30. doi: 10.1016/j.bmcl.2013.04.039. Epub 2013 Apr 25. Bioorg Med Chem Lett. 2013. PMID: 23664099

4

Design, synthesis, and biological evaluation of novel 4-anilinoquinazoline derivatives bearing amino acid moiety as potential EGFR kinase inhibitors.

Zheng YG, Su J, Gao CY, Jiang P, An L, Xue YS, Gao J, Liu Y. Zheng YG, et al. Eur J Med Chem. 2017 Apr 21;130:393-405. doi: 10.1016/j.ejmech.2017.02.061. Epub 2017 Feb 28. Eur J Med Chem. 2017. PMID: 28279846

5

Design and synthesis of a novel photoaffinity probe for labelling EGF receptor tyrosine kinases.

Zheng YG, Wu XQ, Su J, Jiang P, Xu L, Gao J, Cai B, Ji M. Zheng YG, et al. J Enzyme Inhib Med Chem. 2017 Dec;32(1):954-959. doi: 10.1080/14756366.2017.1344979. J Enzyme Inhib Med Chem. 2017. PMID: 28718674 Free PMC article.

6

QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.

Sun M, Zheng Y, Wei H, Chen J, Ji M. Sun M, et al. Among authors: zheng y. J Enzyme Inhib Med Chem. 2009 Oct;24(5):1109-16. doi: 10.1080/14756360802632906. J Enzyme Inhib Med Chem. 2009. PMID: 19555174 Free article.

7

Design and synthesis of novel Gefitinib analogues with improved anti-tumor activity.

Wu X, Li M, Qu Y, Tang W, Zheng Y, Lian J, Ji M, Xu L. Wu X, et al. Among authors: zheng y. Bioorg Med Chem. 2010 Jun 1;18(11):3812-22. doi: 10.1016/j.bmc.2010.04.046. Epub 2010 Apr 21. Bioorg Med Chem. 2010. PMID: 20466555 Free PMC article.

8

Design, synthesis, docking and antitumor activity of quinazolino [3, 4-a] thieno [3, 2-d] pyrimidin-8-one derivatives.

Zheng Y, Wu X, Xue B, Li M, Ji M. Zheng Y, et al. Chem Biol Drug Des. 2010 Sep 1;76(3):285-90. doi: 10.1111/j.1747-0285.2010.01008.x. Epub 2010 Jun 29. Chem Biol Drug Des. 2010. PMID: 20604799

9

Design, synthesis, and in vitro antitumor evaluation of novel phenylaminopyrimidine derivatives.

Zheng Y, Zheng M, Liu Y, Xue Y, Zhang L, An L, Liu L, Ji M. Zheng Y, et al. Among authors: zheng m. Med Chem. 2013 May;9(3):340-50. doi: 10.2174/1573406411309030004. Med Chem. 2013. PMID: 22920155

10

Synthesis of gefitinib from methyl 3-hydroxy-4-methoxy-benzoate.

Li MD, Zheng YG, Ji M. Li MD, et al. Molecules. 2007 Mar 28;12(3):673-8. doi: 10.3390/12030673. Molecules. 2007. Retraction in: Molecules. 2007;12(9):2160. doi: 10.3390/12092160 PMID: 17851420 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,287 results

Search Page

Filters